nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A37 Accounting for missing data in clinical trials of blood pressure (BP) and hypertension
|
Cook, Nancy R. |
|
1996 |
17 |
2S1 |
p. S59-S60 2 p. |
artikel |
2 |
A55 Adapting batch cleaning methods for lymphocyte data to on-line validation routines
|
Carrington, Jane |
|
1996 |
17 |
2S1 |
p. S70- 1 p. |
artikel |
3 |
A08 A data manager training program for oncology clinical trials
|
Casagrande, Chris |
|
1996 |
17 |
2S1 |
p. S42- 1 p. |
artikel |
4 |
A75 Adherence/compliance in a hormone replacement trial: The postmenopausal estrogen/progestins intervention (PEPI) trial perspective
|
Hogan, Patricia |
|
1996 |
17 |
2S1 |
p. S82- 1 p. |
artikel |
5 |
A89 A dynamic approach to recruiting patients in a registry of coronary interventions
|
Holubkov, Richard |
|
1996 |
17 |
2S1 |
p. S90- 1 p. |
artikel |
6 |
A74 A method to maintain blinding in a randomized trial requiring adjustment of doses for only one treatment arm
|
Mercier, Catherine |
|
1996 |
17 |
2S1 |
p. S81- 1 p. |
artikel |
7 |
A23 analysis by intention to treat in randomized clinical trials: A survey of the literature
|
Jansen-McWilliams, Linda |
|
1996 |
17 |
2S1 |
p. S51- 1 p. |
artikel |
8 |
A39 Analysis of agreement data beyond kappa: Application of loglinear modeling to evaluate agreement in disc photograph gradings
|
Hussein, M.E. |
|
1996 |
17 |
2S1 |
p. S60-S61 2 p. |
artikel |
9 |
A40 Analytical issues for Stroke clinical trials
|
Tilley, Barbara C. |
|
1996 |
17 |
2S1 |
p. S61- 1 p. |
artikel |
10 |
A59 An extension of stochastic curtailment for incompletely reported and classified data on recurrent outcomes: The multicenter study of hydroxyurea in sickle cell anemia (MSH)
|
McMahon, Robert P. |
|
1996 |
17 |
2S1 |
p. S72- 1 p. |
artikel |
11 |
A70 An inexpensive electronic system for handling adverse event reports
|
Wong, Kenneth |
|
1996 |
17 |
2S1 |
p. S79- 1 p. |
artikel |
12 |
A52 An interactive voice response system for randomizing patients
|
Assmann, Susan F. |
|
1996 |
17 |
2S1 |
p. S68-S69 2 p. |
artikel |
13 |
A29 A program for large, simple randomized clinical trials — American style
|
Hillis, Argye |
|
1996 |
17 |
2S1 |
p. S55- 1 p. |
artikel |
14 |
A49 Ascertainment of the primary end point in the multicenter study of hydroxyurea in sickle cell anemia (MSH)
|
Barton, F. |
|
1996 |
17 |
2S1 |
p. S67- 1 p. |
artikel |
15 |
A72 Automatic forms processing with Windows 95: Hyperbole?
|
Wong, Kenneth |
|
1996 |
17 |
2S1 |
p. S80- 1 p. |
artikel |
16 |
A34 Clinical monitoring of rating scales in multicenter clinical trials
|
Schafer, Kimberly |
|
1996 |
17 |
2S1 |
p. S57-S58 2 p. |
artikel |
17 |
A35 Clinical trial Monitoring in the face of changing clinical practice
|
Thom, Elizabeth |
|
1996 |
17 |
2S1 |
p. S58-S59 2 p. |
artikel |
18 |
A43 Collection of health care cost data in a VA health services study (CSHS#17)
|
Cramer, Joyce |
|
1996 |
17 |
2S1 |
p. S63- 1 p. |
artikel |
19 |
A26 Combining parallel trials with differing eligibility criteria
|
Fowler, Sarah |
|
1996 |
17 |
2S1 |
p. S52-S53 2 p. |
artikel |
20 |
A73 Comparability of self-report, pill count, and electronically monitored adherence data
|
Dunbar-Jacob, Jacqueline |
|
1996 |
17 |
2S1 |
p. S80-S81 2 p. |
artikel |
21 |
A32 computer-aided clinical monitoring: Results of a controlled experiment
|
Thomas, Ronald G. |
|
1996 |
17 |
2S1 |
p. S56-S57 2 p. |
artikel |
22 |
A03 Computing power in the design of clinical trials using ordered polychotomous logistic regression
|
Ernesto, Christopher |
|
1996 |
17 |
2S1 |
p. S39- 1 p. |
artikel |
23 |
A20 Concurrent medication tracking in an oracle database in the African American Study of Kidney Disease and Hypertension
|
Stewart, Ron |
|
1996 |
17 |
2S1 |
p. S49- 1 p. |
artikel |
24 |
A58 Consequences of data delay in a collaborative international sequentially monitored phase III prophylaxis trial
|
Hurwitz, Shelley |
|
1996 |
17 |
2S1 |
p. S71-S72 2 p. |
artikel |
25 |
A71 Datafax and data quality in a large, multi-center, clinical trial
|
Krause-Steinrauf, Heidi |
|
1996 |
17 |
2S1 |
p. S79-S80 2 p. |
artikel |
26 |
A80 Design of Phase II clinical trials incorporating response and early progression
|
Zee, Benny |
|
1996 |
17 |
2S1 |
p. S85- 1 p. |
artikel |
27 |
A83 Design of the NIDCD/VA hearing aid trial
|
Henderson, William G. |
|
1996 |
17 |
2S1 |
p. S86-S87 2 p. |
artikel |
28 |
A81 Diabetes prevention trial — type I (DPT-1) — design and implementation
|
Rafkin-Mervis, Lisa |
|
1996 |
17 |
2S1 |
p. S85-S86 2 p. |
artikel |
29 |
A47 Differences in endpoint identification by investigators versus independent review
|
Tardiff, Barbara E. |
|
1996 |
17 |
2S1 |
p. S65-S66 2 p. |
artikel |
30 |
A67 Double versus quadruple data entry
|
Maupas, Jean |
|
1996 |
17 |
2S1 |
p. S77- 1 p. |
artikel |
31 |
A42 Economic evaluation alongside clinical trials: A problem or a solution?
|
Haider, Seema |
|
1996 |
17 |
2S1 |
p. S62- 1 p. |
artikel |
32 |
A31 Ethical cost when the therapy target population and the dissemination population do not coincide
|
Boissel, Jean-Pierre |
|
1996 |
17 |
2S1 |
p. S56- 1 p. |
artikel |
33 |
A02 Evaluation of phase I cancer clinical trial designs
|
Ahn, Chul |
|
1996 |
17 |
2S1 |
p. S38- 1 p. |
artikel |
34 |
A09 Experience with interactive data management (IDM) in a Department of Veterans Affairs multi-center randomized clinical trial
|
Sacks, Jerome M. |
|
1996 |
17 |
2S1 |
p. S42-S43 2 p. |
artikel |
35 |
A13 Exploring the information superhighway: Use of the internet in clinical drug trials
|
Carr, Sarah |
|
1996 |
17 |
2S1 |
p. S44-S45 2 p. |
artikel |
36 |
A84 Extending intent-to-treat principles to cluster design clinical trials
|
Hirst, Kathryn |
|
1996 |
17 |
2S1 |
p. S87- 1 p. |
artikel |
37 |
A36 Facilitating the quality assurance process of data collected during the research interview
|
Fischbach, Heidi E. |
|
1996 |
17 |
2S1 |
p. S59- 1 p. |
artikel |
38 |
A69 Feasibility of keying data from screen-displayed facsimile images in the Collaborative Ocular Melanoma Study
|
Diener-West, Marie |
|
1996 |
17 |
2S1 |
p. S78- 1 p. |
artikel |
39 |
A17 Format-independent data collection forms, the world-wide web, and reusable research data management: A proposal
|
Singer, Stephen W. |
|
1996 |
17 |
2S1 |
p. S47- 1 p. |
artikel |
40 |
A21 graphical representation of symptom and concomitant treatment relationships
|
Visèle, Nathalie |
|
1996 |
17 |
2S1 |
p. S49-S50 2 p. |
artikel |
41 |
A28 Impact of continuing education on general practitioners' behaviour: Methodological problems
|
Brun, Catherine |
|
1996 |
17 |
2S1 |
p. S54- 1 p. |
artikel |
42 |
A30 Impact of the results of a trial on medical practice: Opinion survey among participating doctors
|
Blondel, Béatrice |
|
1996 |
17 |
2S1 |
p. S55- 1 p. |
artikel |
43 |
A79 Innovative trial design solutions to problemsposed by a randomized,multinational, double-blindphase III study of cytomegalovirus prohylaxis in AIDS patients
|
Feinberg, Judith |
|
1996 |
17 |
2S1 |
p. S84- 1 p. |
artikel |
44 |
A62 Issues in implementing a multi-centre, placebo controlled sequential design trialof anti-emetic prophylaxis (AEP)inpatients (pts) receiving radiotherapy (R)
|
Palmer, Michael J. |
|
1996 |
17 |
2S1 |
p. S73-S74 2 p. |
artikel |
45 |
A78 Issues in monitoring adherence to protocol using timed urine collections: Methods for assessing the adequacy of urine samples
|
McFarlane, Mary |
|
1996 |
17 |
2S1 |
p. S83-S84 2 p. |
artikel |
46 |
A24 Is the inclusion of the elderly in cancer and cardiovascular clinical trials increasing?
|
Davidson, Michael |
|
1996 |
17 |
2S1 |
p. S51-S52 2 p. |
artikel |
47 |
A61 Likelihood analysis of sequential trials
|
Blume, Jeffrey |
|
1996 |
17 |
2S1 |
p. S73- 1 p. |
artikel |
48 |
A50 Local versus central readings of endometrial biopsies in a multicenter clinical trial
|
Legault, Claudine |
|
1996 |
17 |
2S1 |
p. S67-S68 2 p. |
artikel |
49 |
A63 Managing a blinded 9000-patient coumadin clinic using express mail and facsimile
|
Berdan, Lisa G. |
|
1996 |
17 |
2S1 |
p. S74- 1 p. |
artikel |
50 |
A41 Methodological issues regarding variance estimation in cost evaluation
|
Ducruet, Thierry |
|
1996 |
17 |
2S1 |
p. S61-S62 2 p. |
artikel |
51 |
A22 Methodological quality in randomized trials and statistical heterogeneity in meta-analyses
|
Schulz, Kenneth F. |
|
1996 |
17 |
2S1 |
p. S50-S51 2 p. |
artikel |
52 |
A77 Modeling the association between compliance and response to treatment in primary prevention trials of cholesterol lowering drugs
|
Norrie, John |
|
1996 |
17 |
2S1 |
p. S83- 1 p. |
artikel |
53 |
A64 Number of lines for telephone randomization
|
Kalish, Leslie A. |
|
1996 |
17 |
2S1 |
p. S75- 1 p. |
artikel |
54 |
A46 Patient self-addressed postcard follow-up is inadequate: Results from the Duke Clinical Research Institute
|
Mahaffey, Kenneth W. |
|
1996 |
17 |
2S1 |
p. S64-S65 2 p. |
artikel |
55 |
A66 Personnel certification and turnover in the collaborative ocular melanoma study
|
Church, Renée Y. |
|
1996 |
17 |
2S1 |
p. S76-S77 2 p. |
artikel |
56 |
A15 Pilot-recruitment study for osteoporosis trial: Direct mailing versus GP-preselection
|
Bak, Annette |
|
1996 |
17 |
2S1 |
p. S46- 1 p. |
artikel |
57 |
A86 Potential effects of slower than expected recruitment and proposed changes in eligibility criteria on power in a randomized controlled trial
|
Wright, Elizabeth C. |
|
1996 |
17 |
2S1 |
p. S88- 1 p. |
artikel |
58 |
A65 Procedures for handling criticism and comments from study investigators
|
Gordon, Mae |
|
1996 |
17 |
2S1 |
p. S76- 1 p. |
artikel |
59 |
A38 Proportional hazards model for assessing visual acuity data
|
Wisniewski, Stephen R. |
|
1996 |
17 |
2S1 |
p. S60- 1 p. |
artikel |
60 |
A33 Quality management of a multicenter selective lymphadenectomy trial (MSLT): A model for success
|
Flaherty, Sandra |
|
1996 |
17 |
2S1 |
p. S57- 1 p. |
artikel |
61 |
A88 Randomization to pharmacologic andbehavioral therapy separately within the same study and blinding issues
|
Cnaan, Avital |
|
1996 |
17 |
2S1 |
p. S89- 1 p. |
artikel |
62 |
A14 Recruitment for a large-scale clinical study via the internet
|
Zadnik, K. |
|
1996 |
17 |
2S1 |
p. S45- 1 p. |
artikel |
63 |
A16 Recruitment to breast cancer clinical trials
|
Morrill, Allison C. |
|
1996 |
17 |
2S1 |
p. S46-S47 2 p. |
artikel |
64 |
A68 Results of rekey verification at the clinical centers in the hemodialysis (HEMO) study
|
Gassman, Jennifer |
|
1996 |
17 |
2S1 |
p. S77-S78 2 p. |
artikel |
65 |
A48 Rigorous end point assessment procedures in reducing bias
|
Nelson, J.J. |
|
1996 |
17 |
2S1 |
p. S66- 1 p. |
artikel |
66 |
A01 Samples sizes for phase II trials in multiple sclerosis
|
Schwid, Steven R. |
|
1996 |
17 |
2S1 |
p. S38- 1 p. |
artikel |
67 |
A60 Stopping a clinical trial very early based on sequential conditional probability ratio test
|
Ming, Tan |
|
1996 |
17 |
2S1 |
p. S72-S73 2 p. |
artikel |
68 |
A44 Strategies for including costs in randomized controlled trials of new medical technologies: The implementation of an economic analysis of an aicd (Automatic Implantable Cardiac Defibrillator)
|
Gajary, Elizabeth |
|
1996 |
17 |
2S1 |
p. S63-S64 2 p. |
artikel |
69 |
A04 Survey of collaborators' opinions about study results
|
Weston, Julie |
|
1996 |
17 |
2S1 |
p. S39- 1 p. |
artikel |
70 |
A27 Teaching the next generation of clinical trialists
|
Kelsey, Sheryl F. |
|
1996 |
17 |
2S1 |
p. S53-S54 2 p. |
artikel |
71 |
A45 Team managed hospital based home care: Design of a multi-site randomized trial
|
Weaver, Frances |
|
1996 |
17 |
2S1 |
p. S64- 1 p. |
artikel |
72 |
A18 Technical and architectural problems and solutions associated with registers of clinical trials
|
Strang, Nigel |
|
1996 |
17 |
2S1 |
p. S48- 1 p. |
artikel |
73 |
A06 Termprom investigator survey
|
Hewson, Sheila |
|
1996 |
17 |
2S1 |
p. S40-S41 2 p. |
artikel |
74 |
A76 The impact of method of calculation of electronically monitored adherence data
|
Rohay, Jeffrey M. |
|
1996 |
17 |
2S1 |
p. S82-S83 2 p. |
artikel |
75 |
A87 The impact of using different albumin laboratory methods on eligibility in the HEMO study
|
Beck, Gerald |
|
1996 |
17 |
2S1 |
p. S89- 1 p. |
artikel |
76 |
A82 The importance of the design of a pilot study providing the most exhaustive data for the protocol of a large controlled clinical trial
|
Gardinle, E. |
|
1996 |
17 |
2S1 |
p. S86- 1 p. |
artikel |
77 |
A25 The prognostic profile of the patients is essential for any comparative interpretation of clinical trials
|
Hasford, J. |
|
1996 |
17 |
2S1 |
p. S52- 1 p. |
artikel |
78 |
A56 Three gigabytes of transcranial doppler readings: Logistics of blinding the central readers and quality assurance in a 12 center clinical trial
|
Tighe, Foss |
|
1996 |
17 |
2S1 |
p. S70-S71 2 p. |
artikel |
79 |
A85 Tools for the visualization of patient accrual trends in clinical trials
|
Buzydlowski, Jan W. |
|
1996 |
17 |
2S1 |
p. S88- 1 p. |
artikel |
80 |
A19 Tracking monitoring activities performed at the Coordinating Center
|
Doherty, Irene |
|
1996 |
17 |
2S1 |
p. S48-S49 2 p. |
artikel |
81 |
A07 Training and quality control procedures for remote database management of 24 hour dietary recalls
|
Doroshenko, Linda |
|
1996 |
17 |
2S1 |
p. S41- 1 p. |
artikel |
82 |
A05 Treatment guesses by patients and investigators in a double-blind clinical trial
|
Barton, F. |
|
1996 |
17 |
2S1 |
p. S40- 1 p. |
artikel |
83 |
A57 Use of a registry as control data: Data management issues in combining existing data into an existing registry
|
Kennard, Elizabeth D. |
|
1996 |
17 |
2S1 |
p. S71- 1 p. |
artikel |
84 |
A53 Use of oracle with an interactive voice response system (IVR) to randomize patients in an acute controlled clinical trial
|
McPherson, Joseph A. |
|
1996 |
17 |
2S1 |
p. S69- 1 p. |
artikel |
85 |
Author index
|
|
|
1996 |
17 |
2S1 |
p. S139-S154 16 p. |
artikel |
86 |
A51 Verification of endpoints in a phase 3 HIV clinical trial
|
Ingraham, Peter |
|
1996 |
17 |
2S1 |
p. S68- 1 p. |
artikel |
87 |
A54 Window based data management system for clinical trials
|
Boardman, Chris |
|
1996 |
17 |
2S1 |
p. S69- 1 p. |
artikel |
88 |
Calendar of program
|
|
|
1996 |
17 |
2S1 |
p. S3-S35 33 p. |
artikel |
89 |
Letter from the President
|
|
|
1996 |
17 |
2S1 |
p. S1- 1 p. |
artikel |
90 |
P45 Accessing data from external centralized sources to enhance analysis of a completed clinical trial
|
Abdellatif, Mazen |
|
1996 |
17 |
2S1 |
p. S118-S119 2 p. |
artikel |
91 |
P59 A comparison of quantitative computerized and human panel coronary end point measures: Implications for angiographic trial design
|
Dunn, Meleana E. |
|
1996 |
17 |
2S1 |
p. S128- 1 p. |
artikel |
92 |
P36 A comparison of statistical methodologies for the calculation of lytic units derived from the modeling of natural killer cells
|
Johnson, Paul |
|
1996 |
17 |
2S1 |
p. S113- 1 p. |
artikel |
93 |
P07 A completely automated interactive data management system
|
Othman, Raslan |
|
1996 |
17 |
2S1 |
p. S94-S95 2 p. |
artikel |
94 |
P05 Adapting management techniques after conversion to an onsite, interactive data management system (IDMS)
|
Ellis, Nancy |
|
1996 |
17 |
2S1 |
p. S93-S94 2 p. |
artikel |
95 |
P64 Adverse medical events reported by patients in control groups
|
Raisch, Dennis W. |
|
1996 |
17 |
2S1 |
p. S131- 1 p. |
artikel |
96 |
P37 A mixed models approach to the analysis of the treatment of delayed onset muscle soreness
|
Golloso-Nagpala, Fides R. |
|
1996 |
17 |
2S1 |
p. S113-S114 2 p. |
artikel |
97 |
P53 An approximation of kappa's variance
|
Pintilie, Melania |
|
1996 |
17 |
2S1 |
p. S124-S125 2 p. |
artikel |
98 |
P72 An iterative process for defining nonfatal endpoints in the context of clinical trials
|
Tardiff, Barbara E. |
|
1996 |
17 |
2S1 |
p. S136- 1 p. |
artikel |
99 |
P33 Antidepressant evaluation: Methodological considerations for meta-analysis
|
Cialdella, Philippe |
|
1996 |
17 |
2S1 |
p. S111- 1 p. |
artikel |
100 |
P09 A pilot study for feasibility of long-term patient follow-up after the end of a clinical trial
|
Beck, Gerald |
|
1996 |
17 |
2S1 |
p. S95-S96 2 p. |
artikel |
101 |
P39 A quality control method for single-data entry using remote data entry systems in large compassionate clinical trials
|
Sharma, Inder J. |
|
1996 |
17 |
2S1 |
p. S115- 1 p. |
artikel |
102 |
P15 Are specific trials needed to assess the best treatment duration? Examples in cardiovascular field
|
Gueyffier, François |
|
1996 |
17 |
2S1 |
p. S99-S100 2 p. |
artikel |
103 |
P32 A SAS macro for exploratory data analysis using a Bayesian Belief Network
|
Clarke, Ellis |
|
1996 |
17 |
2S1 |
p. S110- 1 p. |
artikel |
104 |
P56 Assessment and reorganization of educational training programs developed for data managers
|
Edelman, Bonnie |
|
1996 |
17 |
2S1 |
p. S126- 1 p. |
artikel |
105 |
P48 Auditing and verification of clinical data: A coordinating center's role
|
Randall, A.M.Y. |
|
1996 |
17 |
2S1 |
p. S121- 1 p. |
artikel |
106 |
P06 Automated edit system from data entry to site notification
|
Harrison, Merrie Jean |
|
1996 |
17 |
2S1 |
p. S94- 1 p. |
artikel |
107 |
P52 Can the forest plot be simplified without loosing relevant information in meta-analyses?
|
Bijnens, Luc |
|
1996 |
17 |
2S1 |
p. S124- 1 p. |
artikel |
108 |
P30 Challenges in recruiting normal volunteers for clinical trials
|
Herr, Barbara |
|
1996 |
17 |
2S1 |
p. S109- 1 p. |
artikel |
109 |
P49 Combining graphical and tabular displays in data monitoring reports
|
Van Natta, Mark L. |
|
1996 |
17 |
2S1 |
p. S121-S122 2 p. |
artikel |
110 |
P46 Comparability of absolute/percent CD4+ T-lymphocytes completed locally and centrally
|
Donfield, Sharyne |
|
1996 |
17 |
2S1 |
p. S119- 1 p. |
artikel |
111 |
P73 Comparison of investigator and central events review of myocardial infarction rates as a means to improve events classification: Results from GUSTO-IIa
|
Mahaffey, Kenneth W. |
|
1996 |
17 |
2S1 |
p. S136-S137 2 p. |
artikel |
112 |
P51 Concordance of medication adherence measures in primary Raynaud's disease
|
Schlenk, Elizabeth A. |
|
1996 |
17 |
2S1 |
p. S123- 1 p. |
artikel |
113 |
P04 Consistency checks in a multi-centered clinical study
|
Konig, Victoria |
|
1996 |
17 |
2S1 |
p. S93- 1 p. |
artikel |
114 |
P47 Data management for a Phase III international collaborative study (AIDS clinical trial group study 204/Glaxo Wellcome protocol 123-014)
|
Fry, J. |
|
1996 |
17 |
2S1 |
p. S120- 1 p. |
artikel |
115 |
P69 Does workspace effect coordinator performance in a randomized clinical trial?
|
Manos, Kelly S. |
|
1996 |
17 |
2S1 |
p. S134- 1 p. |
artikel |
116 |
P03 Dose titration in the multicenter study of hydroxyurea in sickle cell anemia (MSH)
|
Handy, C. |
|
1996 |
17 |
2S1 |
p. S92- 1 p. |
artikel |
117 |
P54 Drug packaging challenges in a multicenter trial on opiate dependence
|
Johnson, Elaine L. |
|
1996 |
17 |
2S1 |
p. S125- 1 p. |
artikel |
118 |
P08 Edit check: An easy way to clean clinical studies databases
|
Charpentier, B. |
|
1996 |
17 |
2S1 |
p. S95- 1 p. |
artikel |
119 |
P12 Efforts to assess subject participation
|
Clerici, Annette M. |
|
1996 |
17 |
2S1 |
p. S97-S98 2 p. |
artikel |
120 |
P13 Efforts to enhance participation in a low socio-economic status population
|
Clerici, Annette M. |
|
1996 |
17 |
2S1 |
p. S98- 1 p. |
artikel |
121 |
P28 How to achieve successful site participation in a large simple trial
|
Egan, Debra |
|
1996 |
17 |
2S1 |
p. S108- 1 p. |
artikel |
122 |
P71 Impact of the clinical events committee process on data safety monitoring
|
Tardiff, Barbara E. |
|
1996 |
17 |
2S1 |
p. S135- 1 p. |
artikel |
123 |
P63 Informed consent issues when including genetic testing in clinical trials
|
Schafer, Kimberly |
|
1996 |
17 |
2S1 |
p. S130-S131 2 p. |
artikel |
124 |
P58 Intention to treat analysis and the need for supplemental approaches for some trial designs
|
Panzarella, Tony |
|
1996 |
17 |
2S1 |
p. S127-S128 2 p. |
artikel |
125 |
P42 Logistics of interim mortality ascertainment
|
Crow, Sharon W. |
|
1996 |
17 |
2S1 |
p. S116-S117 2 p. |
artikel |
126 |
P57 Longitudinal variability of ultrasonographic measurements of carotid intimal-medial thickness: Results for ACAPS
|
Craven, Timothy |
|
1996 |
17 |
2S1 |
p. S127- 1 p. |
artikel |
127 |
P35 Methodological issues in evaluating graft materials for lumbar spinal fusion
|
Block, Jon E. |
|
1996 |
17 |
2S1 |
p. S112- 1 p. |
artikel |
128 |
P50 Minimization technologies in randomized open intervention studies
|
Weverling, Gerrit J. |
|
1996 |
17 |
2S1 |
p. S122-S123 2 p. |
artikel |
129 |
P26 Monitoring in a large multicentre international clinical trial: The italian experience in core study
|
Bonfanti, E. |
|
1996 |
17 |
2S1 |
p. S106-S107 2 p. |
artikel |
130 |
P11 Monitoring item bias within the SF-36: A bias toward decreased health perception
|
Wasser, Thomas |
|
1996 |
17 |
2S1 |
p. S97- 1 p. |
artikel |
131 |
P17 Multicenter trials and cohort studies — valuable resources for long term studies of disease outcomes
|
Wright, Elizabeth |
|
1996 |
17 |
2S1 |
p. S101- 1 p. |
artikel |
132 |
P62 On-site monitoring of a multicenter clinical trial: Perspectives from the administrative center, data coordinating center, clinical centers, auditors. And the funding agency
|
Howard, Virginia J. |
|
1996 |
17 |
2S1 |
p. S130- 1 p. |
artikel |
133 |
P14 Outcomes of a placebo run-in period in a cancer chemoprevention trial
|
Hudmon, Karen Suchanek |
|
1996 |
17 |
2S1 |
p. S99- 1 p. |
artikel |
134 |
P20 Participant perception of the role and benefits of study coordinators: Results of a pilot study
|
Mitchell, Jayne |
|
1996 |
17 |
2S1 |
p. S103- 1 p. |
artikel |
135 |
P27 Predictors of missed follow-up interviews in a study of asthma among inner-city children
|
Islam, Shaheen U. |
|
1996 |
17 |
2S1 |
p. S107- 1 p. |
artikel |
136 |
P68 Primary outcome verification in a multicenter clinical trial
|
Das, Anita |
|
1996 |
17 |
2S1 |
p. S133-S134 2 p. |
artikel |
137 |
P29 Prognostic significance of cardiac enzyme elevations detected through systematic screening in clinical trials
|
Tardiff, Barbara E. |
|
1996 |
17 |
2S1 |
p. S108-S109 2 p. |
artikel |
138 |
P34 Proposed strategy for identifying the treatment target population
|
Gueyffier, François |
|
1996 |
17 |
2S1 |
p. S111-S112 2 p. |
artikel |
139 |
P18 Prospective case-control studies,following a large multicentre clinical trial: GISSI-2
|
Bonfanti, E. |
|
1996 |
17 |
2S1 |
p. S101-S102 2 p. |
artikel |
140 |
P43 Quality assurance in a multicenter/multidisciplinary clinical trial — A model for a limited budget
|
Stern, Stacey |
|
1996 |
17 |
2S1 |
p. S117- 1 p. |
artikel |
141 |
P74 Quality of life (QL) as an outcome measure in the assessment of nausea (N) and vomiting (V)
|
Pater, J.L. |
|
1996 |
17 |
2S1 |
p. S137- 1 p. |
artikel |
142 |
P01 Randomization systems in an international multicentre clinical trial: The CORE study
|
Santoro, E. |
|
1996 |
17 |
2S1 |
p. S91- 1 p. |
artikel |
143 |
P22 Randomized and non-randomized patients in large clinical trials: The case of GISSI
|
Franzosi, M.G. |
|
1996 |
17 |
2S1 |
p. S104- 1 p. |
artikel |
144 |
P70 Recruitment of study sites for participation in a proposed clinical trial
|
Hewson, Sheila |
|
1996 |
17 |
2S1 |
p. S135- 1 p. |
artikel |
145 |
P02 Reducing variations in care in the acute myocardial infarction (AMI) patient using medical practice guidelines
|
Reed III, James F. |
|
1996 |
17 |
2S1 |
p. S91-S92 2 p. |
artikel |
146 |
P31 Reliability of economic and quality of life data for collection of follow-up clinical outcome information
|
Tardiff, Barbara E. |
|
1996 |
17 |
2S1 |
p. S110- 1 p. |
artikel |
147 |
P25 Representativeness of clinical trial participants: The hemodialysis study
|
Kusek, John W. |
|
1996 |
17 |
2S1 |
p. S106- 1 p. |
artikel |
148 |
P67 Social factors influence dietary satisfaction in the modification of diet in renal disease study
|
Olson, Marian |
|
1996 |
17 |
2S1 |
p. S133- 1 p. |
artikel |
149 |
P60 Standardizing data collection by interviewers on a multi-site longitudinal research study
|
Fischbach, Heidi E. |
|
1996 |
17 |
2S1 |
p. S128-S129 2 p. |
artikel |
150 |
P21 Steps in the development of a disease-specific quality of life measure
|
Fink, Nancy |
|
1996 |
17 |
2S1 |
p. S103-S104 2 p. |
artikel |
151 |
P38 System for monitoring timing of data review and entry: A tool for internal data quality control
|
Zee, Benny |
|
1996 |
17 |
2S1 |
p. S114- 1 p. |
artikel |
152 |
P16 Tailoring interventions for children in the inner-city
|
Mitchell, Herman E. |
|
1996 |
17 |
2S1 |
p. S100-S101 2 p. |
artikel |
153 |
P61 The application of pharmacokinetic modeling to the predication of drug needs during multicenter clinical trials
|
Barnhill, Jamie G. |
|
1996 |
17 |
2S1 |
p. S129- 1 p. |
artikel |
154 |
P40 The design of a windows-based cati software system
|
Goldstein, Robert B. |
|
1996 |
17 |
2S1 |
p. S115-S116 2 p. |
artikel |
155 |
P10 The efficacy of testosterone treatment in HIV-related wasting: Does testosteronereplacement help?
|
Cofrancesco Jr., Joseph |
|
1996 |
17 |
2S1 |
p. S96- 1 p. |
artikel |
156 |
P65 The impact of early closure of a clinical trial on a related study
|
Cloud, Gretchen |
|
1996 |
17 |
2S1 |
p. S131-S132 2 p. |
artikel |
157 |
P23 The role of a regional data coordinating centre (RDCC) in a multi-national large phase-II trial
|
Franzosi, M.G. |
|
1996 |
17 |
2S1 |
p. S104-S105 2 p. |
artikel |
158 |
P55 Treatment discontinuation in a Phase III cytomegalovirus prophylaxis trial: Design and analysis
|
Hurwitz, Shelley |
|
1996 |
17 |
2S1 |
p. S125-S126 2 p. |
artikel |
159 |
P24 Tunnel vision: A flaw to avoid when preparing study materials
|
Liu, Margaret B. |
|
1996 |
17 |
2S1 |
p. S105- 1 p. |
artikel |
160 |
P44 Using SAS and wordperfect to automate the production of study data tables
|
Horney, R.Anne |
|
1996 |
17 |
2S1 |
p. S118- 1 p. |
artikel |
161 |
P66 Variables associated with successful site performance in a large, randomized, chronic heart failure trial
|
Rendall, David |
|
1996 |
17 |
2S1 |
p. S132- 1 p. |
artikel |
162 |
P41 Weeding out bad apples: Monitoring data quality in RCTs
|
Flann, M.A. |
|
1996 |
17 |
2S1 |
p. S116- 1 p. |
artikel |
163 |
P19 Why do patients accept or decline randomization?
|
Rajab, Mohammad Hasan |
|
1996 |
17 |
2S1 |
p. S102- 1 p. |
artikel |
164 |
S11 Internal estimation of the sample size for a t-test
|
Denne, Jonathan S. |
|
1996 |
17 |
2S1 |
p. S43- 1 p. |
artikel |
165 |
S10 Planning clinical trials to evaluate early detection programs
|
Hu, Ping |
|
1996 |
17 |
2S1 |
p. S43- 1 p. |
artikel |
166 |
S12 Standardized computer-based reporting of clinical trials: In support of meta-analysis
|
Sim, Ida |
|
1996 |
17 |
2S1 |
p. S44- 1 p. |
artikel |